1,532.00p+1.00 (+0.07%)05 Mar 2021, 18:45
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Abcam PLC Fundamentals

Company NameAbcam PLCLast Updated2021-03-05
Shares in Issue226.720 mMarket Cap£3.47 bn
PE Ratio263.16Dividend per Share£0.12
Dividend Yield0.22Dividend Cover0.49
EPS£0.06EPS Growth (%)-0.73
PEG0DPS Growth (%)0
Debt Ratio0.2886Debt Equity Ratio0.2398
Asset Equity Ratio1.6144Cash Equity Ratio0.3727
Quick Ratio1.4624Current Ratio1.75
Price To Book Value6.9109ROCE0

Abcam PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Abcam PLC Company Financials

Tangible Assets£164.70 m£37.10 m£25.10 m
Intangible Assets£347.20 m£227.60 m£220.50 m
Total Fixed Assets£532.60 m£274.90 m£254.90 m
Stocks£40.70 m£36.00 m£29.60 m
Cash & Equivalents£187.30 m£87.10 m£90.20 m
Other Assets000
Total Assets£811.40 m£446.70 m£414.80 m
Creditors within 1 year£159.60 m£45.30 m£49.00 m
Creditors after 1 year£149.20 m£16.60 m£14.10 m
Other Liabilities000
Total Liabilities£308.80 m£61.90 m£63.10 m
Net assets£502.60 m£384.80 m£351.70 m
Called up share capital£400,000.00£400,000.00£400,000.00
Share Premium£138.20 m£27.00 m£25.60 m
Profit / Loss£8.40 m£56.40 m£69.10 m
Other Equity£502.60 m£384.80 m£351.70 m
Preference & Minorities000
Total Capital Employed£502.60 m£384.80 m£351.70 m
Debt Ratio£0.1900
Assets / Equity1.61441.61441.6144
Cash / Equity0.37270.37270.3727
Cash Flow202020192018
Cash from operating activities£63.00 m£70.20 m£63.30 m
Cashflow before financing£247.60 m£45.50 m£42.70 m
Increase in Cash£99.50 m-£4.40 m£5.00 m
Turnover£260.00 m£259.90 m£233.20 m
Cost of sales£79.80 m£76.70 m£70.20 m
Gross Profit£180.20 m£183.20 m£163.00 m
Operating Profit£10.50 m£56.10 m£68.80 m
Pre-Tax profit£8.40 m£56.40 m£69.10 m

Abcam PLC Company Background

ActivitiesAbcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.
Latest Interim Date8 Mar 2021
Latest Fiscal Year End Date14 Sep 2020

Abcam PLC Directors

2009-11-03Mr. Timothy George DyeNon-Executive Director
2020-10-05Dr. Jonathan Simon MilnerNon-Executive Director,Deputy Chairman
2016-09-26Mr. Jeffrey Michel IliffeExecutive Director,Chief Financial Officer
2011-08-09Mr. Mark John Alexander WebsterNon-Executive Director
2020-09-18Lady Louise Alexandra Virginia Charlotte Patten of WincantonNon-Executive Director
2014-11-03Mr. Michael RedmondNon-Executive Director,Chairman
2020-09-18Mr. Giles Francis Bertram KerrNon-Executive Director
2014-11-03Mr. Peter Stephen KeenNon-Executive Director
2012-10-22Professor Tony KouzaridesNon-Executive Director
2017-09-22Dr. David James WarwickExecutive Director,Chief Operating Officer
2020-09-18Mr. Peter Vance AllenNon-Executive Director,Chairman
2016-10-31Dr. Anthony Francis MartinNon-Executive Director
2018-09-24Mr. Murray Edwin HennessyExecutive Director,Chief Executive Officer
2009-09-16Dr. David Douglas Cleevely PhD,FIET,FREngNon-Executive Director,Chairman
2011-08-09Dr. Edward William Eddie Powell PhD,FCAExecutive Director,Finance Director
2016-10-31Mr. Michael Alexander Nunes RossNon-Executive Director
2019-11-13Ms. Susan Elizabeth HarrisNon-Executive Director
2020-02-03Mr. Gavin Hilary James Wood Executive Director,Chief Financial Officer
2020-11-04Mr. Alan Thomas HirzelExecutive Director,Chief Executive Officer
2020-09-18Ms. Mara Glickman AspinallNon-Executive Director
2019-10-03Ms. Suzanne SmithLegal Officer and Company Secretary
2021-02-04Mr. Michael Shaun BaldockExecutive Director,Chief Financial Officer

Abcam PLC Contact Details

Company NameAbcam PLC
AddressMilton Road, 330 Cambridge Science Park, Cambridge, CB4 0FL
Telephone+44 01223 696000

Abcam PLC Advisors

RegistrarEquiniti Ltd.
Phone+44 1214157082
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Nominated AdviserJ.P. Morgan Cazenove
Phone+44 2077424000
StockbrokerJ.P. Morgan Cazenove Ltd
Phone+44 2077424000
Remuneration ConsultantDeloitte & Touche LLP
Phone+44 2079363000
Fax+44 2075831198
AuditorPricewaterhouseCoopers LLP
Phone+44 1223460055
Fax+44 1223552336
BankNational Westminster Bank PLC
SolicitorEversheds Sutherland
Phone+44 2079194500
Fax+44 2079194919